Follow this blog:
RSS

AP screws up antibiotics-birth defect story

By | November 3, 2009, 11:22 AM PST

The Associated Press is running a super-scary headline today. “Study ties common antibiotics to birth defects.”

The truth is quite different. We are not talking about first-line antibiotics. Penicillins, erythromycins and cephalosporins have no impact on birth defects. We are not talking here of “common antibiotics.”

We’re talking about two specific antibiotics, sulfonamides (sometimes called sulfa drugs),  and nitrofurantoins, used by only 1 in 100 pregnant women.

These did seem to result in a higher rate of birth defects and scientists want to know why.

Among the better known sulfanomides, to which many people are already alerted by allergies, are Bactrim and Sulfatrim.  They are most commonly prescribed for staph infections and in some cases of pneumonia.

Nitrofurantoins are usually used against urinary tract infections, and go by brand names like Macrobid and Macrodantin.

Here is how the study worked.

CDC researchers analyzed 13,155 cases of 30 different birth defects, drawn from the National Birth Defects Prevention Study. These were compared to 4,941 controls, women located in the same geographical areas whose babies had no birth defects.

What the authors want is more study on why these results occurred. There is really no need to panic, unless you get your news from AP.

Here is their conclusion in full:

“Determining the causes of birth defects is problematic. A single defect can have multiple causes, or multiple seemingly unrelated defects may have a common cause. This study could not determine the safety of drugs during pregnancy, but the lack of widespread increased risk associated with many classes of antibacterials used during pregnancy should be reassuring.”

Not all medical scares are caused by conflicting scientific studies or new insights. Some are caused by sloppy headlines.

Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.

Dana Blankenhorn

About Dana Blankenhorn

Dana Blankenhorn was a contributing editor for SmartPlanet from 2009 to 2010.

Dana Blankenhorn

Dana Blankenhorn

Contributing Editor, Healthcare

Dana Blankenhorn has written for the Chicago Tribune, Advertising Age's "NetMarketing" supplement and founded the Interactive Age Daily for CMP Media. He holds degrees from Rice and Northwestern universities. He is based in Atlanta.

Follow him on Twitter.

Dana Blankenhorn

Dana Blankenhorn

Dana Blankenhorn has been a technology reporter since 1982, a business reporter since 1978, and a writer for as long as he can remember. His Schwab IRA has a few tech stocks in it, most notably some Intel and Applied Materials bought over 10 years ago. But the vast majority of his tiny fortune (emphasis on the word tiny) is invested in mutual funds. He presently writes for no one else but ZDNet, SmartPlanet and himself. But if you've got an opportunity let him know. If he takes the gig he"ll first add it to this disclosure page.

He writes for SmartPlanet and is not an employee of CBS.

If you liked this, don't miss...
The discussion hasn’t started yet. Why don’t you begin it?
Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]

Join the SmartPlanet community and join the conversation! Signing up is fast and free. Don't wait -- we want to hear your opinion!